Anteotech Ltd
ASX:ADO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Anteotech Ltd
Operating Income
Anteotech Ltd
Operating Income Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Anteotech Ltd
ASX:ADO
|
Operating Income
-AU$8.5m
|
CAGR 3-Years
15%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
-9%
|
|
|
Genetic Technologies Ltd
ASX:GTG
|
Operating Income
-AU$7m
|
CAGR 3-Years
3%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
4%
|
|
|
Proteomics International Laboratories Ltd
ASX:PIQ
|
Operating Income
-AU$9.8m
|
CAGR 3-Years
-19%
|
CAGR 5-Years
-28%
|
CAGR 10-Years
N/A
|
|
|
T
|
Trajan Group Holdings Ltd
ASX:TRJ
|
Operating Income
AU$5.5m
|
CAGR 3-Years
3%
|
CAGR 5-Years
30%
|
CAGR 10-Years
N/A
|
|
|
Cryosite Ltd
ASX:CTE
|
Operating Income
AU$3m
|
CAGR 3-Years
22%
|
CAGR 5-Years
28%
|
CAGR 10-Years
22%
|
|
|
E
|
EZZ Life Science Holdings Ltd
ASX:EZZ
|
Operating Income
AU$13.3m
|
CAGR 3-Years
60%
|
CAGR 5-Years
51%
|
CAGR 10-Years
N/A
|
|
Anteotech Ltd
Glance View
AnteoTech Ltd. is a global nano-technology company, which develops, manufactures, and distributes products for the life sciences, clinical diagnostics and bio-separations markets. The company is headquartered in Eight Mile Plains, Queensland. The company went IPO on 2000-04-11. The firm is focused on the development and commercialization of its intellectual property of specialized surfaces used in the life sciences, diagnostics, energy and medical devices markets. The firm's products include AnteoCoat, AnteoBind and AnteoRelease, which are used in the energy, diagnostic and medical device markets. The firm's AnteoBind is an aqueous nanosized molecular glue (polymeric metal ions) used in a single-step process to facilitate multivalent coordination to bind carbohydrate polymers, antibodies, and proteins to synthetic substrates in assay development. The firm is also developing, SARS-CoV-2 Ag rapid test, which is a single-use, disposable, lateral flow test for the qualitative detection of SARS-CoV-2 nucleocapsid antigen in nasopharyngeal specimens collected from individuals who are suspected of COVID-19 infection.
See Also
What is Anteotech Ltd's Operating Income?
Operating Income
-8.5m
AUD
Based on the financial report for Dec 31, 2025, Anteotech Ltd's Operating Income amounts to -8.5m AUD.
What is Anteotech Ltd's Operating Income growth rate?
Operating Income CAGR 10Y
-9%
Over the last year, the Operating Income growth was 25%. The average annual Operating Income growth rates for Anteotech Ltd have been 15% over the past three years , -12% over the past five years , and -9% over the past ten years .
